DD 264:2007 is a Draft for Development (DD) that specifies the requirements and provides guidance for the application of Braille to the labelling of medicinal products.
The provision of information on medicinal products in alternative formats, suitable for blind and partially-sighted people, is also addressed.
The labelling of medicinal products (and associated package information leaflet; see Annexes A and B) placed on the market and incorporating Braille in accordance with this Draft for Development meets the requirements of the UK implementation [4] [5], of the European Directive 2001/83/EC Article 56 (a) as amended by Directive 2004/27/EC [1].
The general principles in DD264 Draft for Development can be applied in other sectors, as appropriate